Celyad Oncology SA (EBR:CYAD)

Celyad Oncology Revenue

In the year 2024, Celyad Oncology had annual revenue of 186.00K EUR with 82.35% growth. Celyad Oncology had revenue of 172.00K in the half year ending December 31, 2024.

• Revenue: 186.00K
• Revenue Growth: +82.35%
• P/S Ratio: 86.87
• Revenue / Employee: 10.33K
• Employees: 19
• Market Cap: 16.16M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	186.00K	84.00K	82.35%
Dec 31, 2023	102.00K	-	-
Dec 31, 2022	-	-	-
Dec 31, 2021	-	-	-
Dec 31, 2020	5.00K	-1.00K	-16.67%